Cloudmd Software Services Stock Cash And Equivalents
CloudMD Software Services fundamentals help investors to digest information that contributes to CloudMD Software's financial success or failures. It also enables traders to predict the movement of CloudMD Pink Sheet. The fundamental analysis module provides a way to measure CloudMD Software's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CloudMD Software pink sheet.
CloudMD |
CloudMD Software Services Company Cash And Equivalents Analysis
CloudMD Software's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current CloudMD Software Cash And Equivalents | 29.7 M |
Most of CloudMD Software's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CloudMD Software Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, CloudMD Software Services has 29.7 M in Cash And Equivalents. This is 96.38% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The cash and equivalents for all United States stocks is 98.9% higher than that of the company.
CloudMD Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CloudMD Software's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CloudMD Software could also be used in its relative valuation, which is a method of valuing CloudMD Software by comparing valuation metrics of similar companies.CloudMD Software is currently under evaluation in cash and equivalents category among its peers.
CloudMD Fundamentals
| Return On Equity | -0.88 | |||
| Return On Asset | -0.0595 | |||
| Profit Margin | (1.06) % | |||
| Operating Margin | (0.17) % | |||
| Current Valuation | 45.4 M | |||
| Shares Outstanding | 293.29 M | |||
| Shares Owned By Insiders | 1.26 % | |||
| Shares Owned By Institutions | 0.72 % | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 0.29 X | |||
| Revenue | 102.33 M | |||
| Gross Profit | 5.76 M | |||
| EBITDA | (20.91 M) | |||
| Net Income | (30.73 M) | |||
| Cash And Equivalents | 29.7 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 22.13 M | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 1.67 X | |||
| Book Value Per Share | 0.43 X | |||
| Cash Flow From Operations | (21.86 M) | |||
| Earnings Per Share | (0.10) X | |||
| Number Of Employees | 11 | |||
| Beta | 1.59 | |||
| Market Capitalization | 45.15 M | |||
| Total Asset | 327.36 M | |||
| Z Score | 1.2 | |||
| Net Asset | 327.36 M |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in CloudMD Pink Sheet
If you are still planning to invest in CloudMD Software Services check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CloudMD Software's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |